FDA Authorizes Moderna and Pfizer-BioNTech Bivalent COVID-19 Vaccines for Use as a Booster Dose in Younger Age Groups

By ACA | October 14, 2022

Source: Food and Drug Administration
Related MedlinePlus Pages: COVID-19 Vaccines

Posted in Uncategorized